Family Medicine · Yakima, WA
NPI
1033130646
Since 2006
Specialty
Family Medicine
Code 207Q00000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
402 S 12th Ave
Yakima, WA, 98902
Phone (509) 574-6139
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$2.4M
28,364 prescriptions
Company payments, 2025
$748
From 4 companies
Medicare prescription drug claims, 2024
In 2024, the drug Paul E Emmans Jr. prescribed most often to Medicare patients was Atorvastatin Calcium, with 1,771 prescriptions and refills. In total Paul E Emmans Jr. wrote 28,364 Medicare prescriptions that cost $2.4M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-10-20.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Atorvastatin Calcium Generic | 1,771 | 1,773 | 257 | $31K |
| Levothyroxine Sodium Generic | 1,113 | 1,115 | 163 | $14K |
| Eliquis Apixaban | 884 | 884 | 94 | $250K |
| Gabapentin Generic | 861 | 861 | 135 | $23K |
| Furosemide Generic | 834 | 834 | 127 | $6,673 |
| Potassium Chloride Generic | 775 | 776 | 129 | $21K |
| Amlodipine Besylate Generic | 688 | 688 | 118 | $8,693 |
| Metoprolol Succinate Generic | 621 | 621 | 111 | $13K |
| Lisinopril Generic | 608 | 608 | 98 | $8,400 |
| Sertraline Hcl Generic | 524 | 524 | 97 | $8,521 |
| Losartan Potassium Generic | 509 | 509 | 90 | $9,945 |
| Pantoprazole Sodium Generic | 496 | 496 | 91 | $11K |
| Tamsulosin Hcl Generic | 484 | 484 | 79 | $11K |
| Metformin Hcl Generic | 450 | 450 | 81 | $7,745 |
| Quetiapine Fumarate Generic | 405 | 405 | 66 | $11K |
Brand drugs: 4,742 claims; generic drugs: 23,565 claims; opioid claims: 436.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Paul E Emmans Jr. $748 ($748 in general payments such as food, travel and fees) from 4 companies. The largest payer was ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) with $348.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.